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 Calcium balance in chronic kidney 
disease: walking the tightrope 
 Pieter  Evenepoel 1 ,  Liesbeth  Viaene 1 and  Bjorn  Meijers 1 
 Calcium supplements for prevention and treatment of mineral and bone 
disorders in chronic kidney disease (CKD) have been alternately praised 
and damned. Clinical evidence in favor of either attitude has been 
lacking. The calcium balance study by Spiegel and Brady in patients with 
late stage 3 and stage 4 CKD suggests that CKD subjects ingesting 
2000  mg of elemental calcium per day are in marked positive balance. 
Methodological limitations such as unproven steady state warrant 
caution and confirmatory studies. 
 Kidney International (2012)  81, 1057 – 1059.  doi: 10.1038/ki.2012.33 
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 Calcium is an essential nutrient that plays 
a vital role in neuromuscular function, 
many enzyme-mediated processes, and 
blood clotting and provides skeletal rigid-
ity by virtue of its phosphate salts. Its 
non-structural roles require the strict 
maintenance of ionized calcium concen-
tration in tissue fl uids, if necessary, at the 
expense of the skeleton. Calcium defi -
ciency has been known for many years to 
jeopardize the skeleton in the long term. 
Recently, concerns have also grown that 
calcium supply in excess of the require-
ments may increase cardiovascular risk. 1 
Avoiding calcium defi ciency and over-
load, thus, is of utmost importance. 
 In normal adults, the rate of calcium 
absorption from the gastrointestinal tract 
matches the rate of losses from the body 
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through the bowel, kidneys, skin, hair, and 
nails; that is, calcium balance is neutral 
( Figure 1 ). Age, bone disease, hormonal 
status, and exercise have all been shown 
to aff ect calcium balance. 2 An impaired 
gastrointestinal absorption, related to low 
1,25-dihydroxyvitamin D 3 levels, and a 
decreased renal excretory capacity may 
render chronic kidney disease (CKD) 
patients at risk for either a negative or a 
positive calcium balance. However, stud-
ies investigating calcium balance in CKD 
are scant, probably because balance stud-
ies are labor-intensive and demanding. 
Th e new study by Spiegel and Brady 3 (this 
issue), therefore, is highly welcomed. 
Th ese investigators performed balance 
studies in six patients with late stage 3 and 
stage 4 CKD and six control subjects con-
suming an 800- and a 2000-mg elemental 
calcium diet. Classical balance studies 
provide data for apparent absorption 
(intake minus fecal) and net retention 
(intake minus fecal minus urinary) and 
the corresponding coeffi  cients. Th e main 
fi nding of the study is that CKD patients 
and healthy controls are in markedly pos-
itive calcium balance when ingesting 
2000  mg elemental calcium, with calcium 
balance being signifi cantly greater in CKD 
patients than in controls (759 versus 
464  mg / d, mean). When ingesting an 800-
mg calcium diet, conversely, both CKD 
patients and controls were in neutral to 
slightly negative calcium balance. On the 
basis of these observations the authors 
conclude that total elemental calcium 
intake should be within 800 – 1200  mg / d to 
prevent calcium defi ciency and calcium 
loading, respectively. Th is implies that 
calcium supplements and calcium-con-
taining phosphate binders are virtually 
completely to be avoided in CKD, even in 
patients not yet on dialysis. Is the evidence 
strong enough to support such a far-
reaching conclusion? Several questions 
need to be raised and warrant caution. 
 A fi rst question to be asked is whether 
or not the study participants were in 
steady state during calcium loading. It is 
well accepted that balances can be assessed 
only when patients are in steady state, that 
is, in the absence of major fl uctuations in 
the homeostatic processes. Balance stud-
ies thus require suffi  cient equilibration 
time. A key question is what is suffi  cient 
time. Although there is no strong guid-
ance from the literature, the 7-day equili-
bration period in the study by Spiegel and 
Brady 3 is rather short and might have 
been too short. Th e mean duration of bal-
ances in 210 studies from eight publica-
tions used in a recent report from the 
Food and Agriculture Association of the 
United Nations and the World Health 
Organization was 90 days. 4 Uncertainty as 
to whether a steady state is reached during 
calcium loading should especially caution 
against long-term extrapolation. Extrapo-
lating from current data, a CKD patient 
treated with 4  g of calcium carbonate 
(1600  mg elemental calcium) would 
accrue approximately 2.8  kg elemental 
calcium over a 10-year time span. Th is 
amount of elemental calcium corresponds 
to about 6.8  kg of hydroxyapatite (1  mol 
Ca 10 (PO 4 ) 6 (OH) 2  =  1004  g; 1  mol Ca  = 
40  g), that is, roughly half the weight of the 
skeleton of a 68-kg person, which is hard 
to believe. Th ese kinds of calculations, 
although tricky, at least raise doubts. 
Nonetheless, preliminary data from a 
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recent 3 – week balance study in CKD 
patients ( n  =  3) by Hill  et al. , presented at 
the last American Society of Nephrology 
meeting (Kidney Week, Philadelphia, 
2011, TH-OR015), corroborate the fi nd-
ings of Spiegel and Brady. 3 Patients ingest-
ing 500  mg of elemental calcium three 
times a day with meals showed a markedly 
positive calcium balance (  +  404  mg / d), 
despite stable parathyroid hormone 
levels. It should be emphasized that this 
study, besides low patient number, is 
equally hampered by unproven steady 
state, despite the longer equilibration 
period. In future studies, steady state 
should ideally be confi rmed by repeated 
measurements at intervals of suffi  cient 
duration (for example, 2 weeks) showing 
equal apparent absorption and net reten-
tion coeffi  cients. 
 A second question relates to the vali dity 
of the balance data obtained during 
calcium loading. Th e validity of the results 
largely depends on how accurately the 
intake and output parameters are esti-
mated. In the study by Spiegel and Brady, 3 
feces and urine were collected for only a 
short time period. In addition, because of 
problems with the transit marker, the 24-
h calcium losses in stool were calculated 
rather than directly determined. Th ese 
calculations assumed a neutral phospho-
rus balance, which again cannot be 
proven. Calcium is a well-known phos-
phate binder, and phosphorus balance 
may be hypothesized to be at least tran-
siently (more) negative during calcium 
loading. Consequently, the  ‘ calculated ’ 
calcium balance overestimates the  ‘ true ’ 
amounts retained during calcium loading. 
Skepticism on the validity of the data is 
fueled by two other observations made in 
the margin of the study. First, the authors 
report that the estimated percentage of 
ingested dietary calcium absorbed 
increased from 5 to 47 % (mean) in CKD 
subjects and from 16 to 41 % in controls 
on the 800- and 2000-mg calcium diets, 
respectively. Th is increase of the net frac-
tional absorption during calcium loading 
is unexpected and opposite to what has 
been observed by others. 4 Second, para-
thyroid hormone levels significantly 
decreased during calcium loading, but the 
absolute decline was marginal and much 
less than one would expect if the calcium 
balance was truly positive by 759  mg / d. 
 As dietary calcium and phosphorus 
intake averages 800 and 1600  mg / d, 
respectively, in CKD patients, the above-
mentioned objections of unproven steady 
state do not apply at the time of the base-
line examination. In agreement with pre-
vious studies, 4,5 CKD patients ingesting 
their usual diet were found to be in neu-
tral or in slightly negative calcium balance, 
even when insensible losses, which have 
been estimated at 40 – 80  mg / d, are not 
accounted for. Acknowledging that vascu-
lar calcifi cation is observed in about 70 % 
of patients with stage 3 – 4 CKD 6 and that 
calcium is rarely prescribed to these 
patients (either as a supplement or as a 
phosphate binder), it may be concluded 
that exogenous calcium plays only a minor 
role in the pathogenesis of vascular calci-
fi cation. Opposite to vascular calcifi cation, 
bone mineral content decreases with the 
progression of CKD. 7 Although it needs 
to be emphasized that calcium defi ciency 
and negative calcium balance must sooner 
or later lead to osteoporosis, this does not 
mean that all osteoporosis can be attrib-
uted to calcium defi ciency. Nonetheless, it 
would probably be generally agreed that 
any form of osteoporosis must inevitably 
be aggravated by negative external cal-
cium balance. Such negative balance — 
even for short periods — is prejudicial 
because it takes so much longer to rebuild 
bone than to destroy it. Bone that is lost, 
even during short periods of calcium defi -
ciency, is only slowly replaced when ade-
quate amounts of calcium become 
available. All together, these data indicate 
that intestinal calcium fl uxes are only a 
small component of overall balance; what 
really matters is the movement in and out 
of the bone, where 99 % of the body cal-
cium is stored. 
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 Figure 1  |  Calcium balance: components and consequences. 
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 Notably, the mean net fractional intes-
tinal calcium absorption during habitual 
calcium intake was remarkably low in 
CKD patients (5 % as opposed to 16 % in 
controls). Th is low fi gure in CKD patients 
corresponds to data from previous bal-
ance studies. 5,8 Isotope tracer studies, 9,10 
overall, yielded higher fractional intestinal 
calcium absorption rates (up to 25 % ) and 
less pronounced differences between 
healthy subjects and CKD patients. Tracer 
techniques, however, may overestimate 
real calcium absorption substantially, as 
they do not account for impaired calcium 
release from food (digestion and solubili-
zation), which may be especially relevant 
in pathological conditions such as 
CKD. 11 – 13 Tracer techniques moreover 
require complex modeling that so far has 
not been validated in CKD. 
 In conclusion, Spiegel and Brady 3 should 
be heralded for providing highly needed 
calcium balance data in patients with CKD. 
Although it is currently clear that patients 
with CKD consuming their habitual diet 
are in neutral or even in slightly negative 
calcium balance, additional balance studies 
with adequate equilibration times and long 
collecting periods are required to teach 
us whether — and, if so, to what extent —
 calcium supplementation renders the 
calcium balance positive. Preferably, these 
balance studies should be combined with 
validated isotope techniques to defi ne the 
destination of the excess calcium — the soft  
tissues or the bone. Given the enormous 
health implications and the current trend 
to initiate mineral metabolism therapy, 
including phosphate binders, in early-stage 
CKD, these studies are eagerly awaited. 
Undoubtedly, these studies will help us to 
walk the tightrope of health. 
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